116 related articles for article (PubMed ID: 38319157)
21. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
22. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.
Powers GL; Hammer KD; Domenech M; Frantskevich K; Malinowski RL; Bushman W; Beebe DJ; Marker PC
Mol Cancer Res; 2015 Jan; 13(1):149-60. PubMed ID: 25149359
[TBL] [Abstract][Full Text] [Related]
24. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
25. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gsα correlates with hallmark histopathological changes seen in fibrous dysplastic bone.
Raimondo D; Remoli C; Astrologo L; Burla R; La Torre M; Vernì F; Tagliafico E; Corsi A; Del Giudice S; Persichetti A; Giannicola G; Robey PG; Riminucci M; Saggio I
PLoS One; 2020; 15(1):e0227279. PubMed ID: 31999703
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast.
Tao X; He H; Peng J; Xu R; Fu J; Hu Y; Li L; Yang X; Feng X; Zhang C; Zhang L; Yu X; Shen A; Huang K; Fu Q
Pharmacol Res; 2022 Jan; 175():106004. PubMed ID: 34826603
[TBL] [Abstract][Full Text] [Related]
27. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
[TBL] [Abstract][Full Text] [Related]
28. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
29. GNAS mutations are present in colorectal traditional serrated adenomas, serrated tubulovillous adenomas and serrated adenocarcinomas with adverse prognostic features.
Liu C; McKeone DM; Walker NI; Bettington ML; Leggett BA; Whitehall VLJ
Histopathology; 2017 Jun; 70(7):1079-1088. PubMed ID: 28164369
[TBL] [Abstract][Full Text] [Related]
30. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma.
Wang XQ; Xu H; Wang CH; Xie H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3077-3084. PubMed ID: 32271425
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D.
He N; Kim N; Song M; Park C; Kim S; Park EY; Yim HY; Kim K; Park JH; Kim KI; Zhang F; Mills GB; Yoon S
Mol Cancer Ther; 2014 Oct; 13(10):2463-73. PubMed ID: 25122068
[TBL] [Abstract][Full Text] [Related]
33. Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis.
Gao R; Guo W; Fan T; Pang J; Hou Y; Feng X; Li B; Ge W; Fan T; Zhang T; Lu J; Jing H; Jin M; Yan C; Wang J
Exp Mol Med; 2022 Aug; 54(8):1201-1213. PubMed ID: 35999453
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
Long XD; Xiong J; Mo ZH; Dong CS; Jin P
BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
[TBL] [Abstract][Full Text] [Related]
35. Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.
Vinogradova TM; Sirenko S; Lukyanenko YO; Yang D; Tarasov KV; Lyashkov AE; Varghese NJ; Li Y; Chakir K; Ziman B; Lakatta EG
Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e005896. PubMed ID: 29880528
[TBL] [Abstract][Full Text] [Related]
36. Analysis of genetic alterations identifies the frequent mutation of GNAS in colorectal laterally spreading tumors.
Nong Y; Zhang Y; Zhang Y; Pan L; Chen J; Zhu C; Han L; Li A; Liu S
Cancer Commun (Lond); 2020 Nov; 40(11):636-640. PubMed ID: 32762003
[No Abstract] [Full Text] [Related]
37. Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors.
Tirosh A; Jin DX; De Marco L; Laitman Y; Friedman E
Genes Chromosomes Cancer; 2020 Sep; 59(9):503-516. PubMed ID: 32337806
[TBL] [Abstract][Full Text] [Related]
38. LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.
Liu Y; Li L; Wang JY; Gao F; Lin X; Lin SS; Qiu ZY; Liang ZH
Mol Cell Biochem; 2023 Apr; 478(4):707-719. PubMed ID: 36036334
[TBL] [Abstract][Full Text] [Related]
39. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
Delyon J; Servy A; Laugier F; André J; Ortonne N; Battistella M; Mourah S; Bensussan A; Lebbé C; Dumaz N
Oncogene; 2017 Jun; 36(23):3252-3262. PubMed ID: 28092671
[TBL] [Abstract][Full Text] [Related]
40. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas.
Linglart A; Mahon MJ; Kerachian MA; Berlach DM; Hendy GN; Jüppner H; Bastepe M
Endocrinology; 2006 May; 147(5):2253-62. PubMed ID: 16484323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
